Cite
Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.
MLA
Zhang, Ming-Xing, et al. “Transcriptional Control of the MUC16 Promoter Facilitates Follicle-Stimulating Hormone Peptide-Conjugated ShRNA Nanoparticle-Mediated Inhibition of Ovarian Carcinoma in Vivo.” Drug Delivery, vol. 25, no. 1, Jan. 2018, pp. 797–806. EBSCOhost, https://doi.org/10.1080/10717544.2018.1451934.
APA
Zhang, M.-X., Hong, S.-S., Cai, Q.-Q., Zhang, M., Chen, J., Zhang, X.-Y., & Xu, C.-J. (2018). Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo. Drug Delivery, 25(1), 797–806. https://doi.org/10.1080/10717544.2018.1451934
Chicago
Zhang, Ming-Xing, Shan-Shan Hong, Qing-Qing Cai, Meng Zhang, Jun Chen, Xiao-Yan Zhang, and Cong-Jian Xu. 2018. “Transcriptional Control of the MUC16 Promoter Facilitates Follicle-Stimulating Hormone Peptide-Conjugated ShRNA Nanoparticle-Mediated Inhibition of Ovarian Carcinoma in Vivo.” Drug Delivery 25 (1): 797–806. doi:10.1080/10717544.2018.1451934.